RETINAL DYSTROPHY

Clinical trials for RETINAL DYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new RETINAL DYSTROPHY trials appear

Sign up with your email to follow new studies for RETINAL DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New eye injection shows promise for rare Blindness-Causing gene mutation

Disease control Completed

This early-stage study tested a new drug, VP-001, given as an injection into the eye to see if it is safe for people with a rare genetic eye disease caused by a PRPF31 mutation. Seventeen adults took part. The main goal was to check for side effects, not to measure vision improve…

Matched conditions: RETINAL DYSTROPHY

Phase: PHASE1 • Sponsor: PYC Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

RETINAL DYSTROPHY

Get alerted when new RETINAL DYSTROPHY trials appear

New eye injection shows promise for rare Blindness-Causing gene mutation